Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31The principal activity of the company during the year was that of plastic surgery.2023-04-01false25falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 03438473 2023-04-01 2024-03-31 03438473 2022-04-01 2023-03-31 03438473 2024-03-31 03438473 2023-03-31 03438473 c:Director1 2023-04-01 2024-03-31 03438473 d:PlantMachinery 2023-04-01 2024-03-31 03438473 d:PlantMachinery 2024-03-31 03438473 d:PlantMachinery 2023-03-31 03438473 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 03438473 d:FurnitureFittings 2023-04-01 2024-03-31 03438473 d:FurnitureFittings 2024-03-31 03438473 d:FurnitureFittings 2023-03-31 03438473 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 03438473 d:OfficeEquipment 2023-04-01 2024-03-31 03438473 d:OfficeEquipment 2024-03-31 03438473 d:OfficeEquipment 2023-03-31 03438473 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 03438473 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 03438473 d:CurrentFinancialInstruments 2024-03-31 03438473 d:CurrentFinancialInstruments 2023-03-31 03438473 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 03438473 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 03438473 d:ShareCapital 2024-03-31 03438473 d:ShareCapital 2023-03-31 03438473 d:RetainedEarningsAccumulatedLosses 2024-03-31 03438473 d:RetainedEarningsAccumulatedLosses 2023-03-31 03438473 c:OrdinaryShareClass1 2023-04-01 2024-03-31 03438473 c:OrdinaryShareClass1 2024-03-31 03438473 c:FRS102 2023-04-01 2024-03-31 03438473 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 03438473 c:FullAccounts 2023-04-01 2024-03-31 03438473 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 03438473 2 2023-04-01 2024-03-31 03438473 6 2023-04-01 2024-03-31 03438473 3 2024-03-31 03438473 3 2023-03-31 03438473 f:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 03438473














PLASTIC SURGERY SERVICES LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

 
PLASTIC SURGERY SERVICES LIMITED
 

CONTENTS



Page
Statement of Financial Position
 
1 - 2
Notes to the Financial Statements
 
3 - 8


 
PLASTIC SURGERY SERVICES LIMITED
REGISTERED NUMBER:03438473

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
-
11,652

Investments
 5 
-
1

  
-
11,653

Current assets
  

Debtors: amounts falling due within one year
 6 
552,889
254,622

Cash at bank and in hand
  
1,501,514
2,083,717

  
2,054,403
2,338,339

Current liabiities
  

Creditors: amounts falling due within one year
 7 
(332,120)
(575,085)

Net current assets
  
 
 
1,722,283
 
 
1,763,254

  

Net assets
  
1,722,283
1,774,907


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
  
1,722,183
1,774,807

  
1,722,283
1,774,907


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
PLASTIC SURGERY SERVICES LIMITED
REGISTERED NUMBER:03438473
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 18 November 2024.




N Carver
Director

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

Plastic Surgery Services Limited is a private limited liability company registered in England and Wales. Its registered office address is at 5 Elstree Gate, Elstree Way, Borehamwood, Hertfordshire, WD6 1JD.
The principal activity of the company during the year was that of plastic surgery.
The company's functional and presentational currency is £ sterling.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
2.2

Revenue recognition

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. 
Revenue from plastic surgery procedures is recognised when the services are performed.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on the following basis:

Plant and machinery
-
15%
reducing balance
Fixtures and fittings
-
15%
reducing balance
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Comprehensive Income.

Page 3

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.4

Valuation of investments

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of Comprehensive Income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.5

Basic financial instruments

The company only enters into transactions that result in basic financial instruments such as trade and other debtors, trade and other creditors, cash at bank and in hand and loans with related parties.
Trade debtors, other debtors and loans to related parties are recognised initially at the transaction price less attributable transaction costs. Trade creditors, other creditors and loans from related parties are recognised initially at transaction price plus attributable transaction costs. Subsequently they are measured at amortised cost using the effective interest method, less any impairment losses in the case of trade and other debtors, and loans to related parties.
Interest bearing borrowings, such bank loans, classified as basic financial instruments are recognised initially at the present value of future payments discounted at a maket rate of interest. Thereafter they are stated at amortised cost using the effective interest method.
Cash and cash equivalents comprise cash balances and call deposits.

 
2.6

Pensions

The company contributes to a defined contribution pension scheme and the pension charge represents the amount payable by the company to the fund in respect of the year.

 
2.7

Interest income

Interest income is recognised in the Statement of Comprehensive Income using the effective interest method.

Page 4

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.8

Current and deferred taxation

Tax is recognised in the Statement of Comprehensive Income, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date.
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Statement of Financial Position date, except that:
1. The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
2. Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.
Deferred tax balances are not recognised in respect of permanent differences. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 5).

Page 5

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£



Cost


At 1 April 2023
13,610
19,302
45,004
77,916


Disposals
(13,610)
(19,302)
(45,004)
(77,916)



At 31 March 2024

-
-
-
-





At 1 April 2023
8,095
18,410
39,759
66,264


Charge for the year on owned assets
176
-
721
897


Disposals
(8,271)
(18,410)
(40,480)
(67,161)



At 31 March 2024

-
-
-
-



Net book value



At 31 March 2024
-
-
-
-



At 31 March 2023
5,515
892
5,245
11,652

Page 6

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

5.


Fixed asset investments





Other fixed asset investments

£





At 1 April 2023
628,000


Disposals
(628,000)



At 31 March 2024

-





At 1 April 2023
627,999


Impairment on disposals
(627,999)



At 31 March 2024

-



Net book value



At 31 March 2024
-



At 31 March 2023
1


6.


Debtors

2024
2023
£
£


Other debtors
491,766
197,508

Prepayments and accrued income
61,123
57,114

552,889
254,622


Included within other debtors due within one year is a loan to N Carver, a director, amounting to £41,933 (2023 - £197,508). Interest has been charged on this loan at HMRC's beneficial loan rate of 2.25% (2023 - 2%). The director intends to repay the loan within 9 months of the reporting date.

Page 7

 
PLASTIC SURGERY SERVICES LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Taxation and social security
325,855
416,621

Other creditors
-
572

Accruals and deferred income
6,265
157,892

332,120
575,085



8.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 Ordinary shares of £1 each
100
100


 
Page 8